Through RT–PCR and immunohistochemistry, we found that the expression level of FXR in hilar cholangiocarcinoma was lower than that in the control group and sham operation group, and the differences in expression produced significant differences. Here, NR1H4 is linked to hilar cholangiocarcinoma.